The additive effects of alcohol and benzodiazepines on driving

Canadian Journal of Public Health

Volumn 101, Issue 5, 2010, Pages 353-357

  Maxwell, Hillary G ^a   Dubois, Sacha ^b   Weaver, Bruce ^c   Bédard, Michel ^d  

^a Centre for Neuro Skills   (United States)

^b St Joseph's Care Group   (United States)

^c LAKEHEAD UNIVERSITY   (Canada)

^d LAKEHEAD UNIVERSITY   (Canada)

Author keywords

Alcohol drinking; Automobile driving; Benzodiazepines; Case control studies; Drug interactions

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CENTRAL DEPRESSANT AGENT;

ADULT; ARTICLE; BLOOD; CANADA; CAR DRIVING; DRINKING BEHAVIOR; DRUG POTENTIATION; FEMALE; HUMAN; MALE; MIDDLE AGED; RISK FACTOR; STATISTICS; TRAFFIC ACCIDENT;

ACCIDENTS, TRAFFIC; ADULT; ALCOHOL DRINKING; AUTOMOBILE DRIVING; BENZODIAZEPINES; CANADA; CENTRAL NERVOUS SYSTEM DEPRESSANTS; DRUG SYNERGISM; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 79952234120     PISSN: 00084263     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03404852     Document Type: Article

References (25)

1. Tu K, Mamdani MM, Hux JE, Tu JB. Progressive trends in the prevalence of benzodiazepine prescribing in older people in Ontario, Canada. J Am Geriatr Soc 2001;49:1341-45.
2. Vanakoski J, Mattila MJ, Seppala T. Driving under light and dark conditions: Effects of alcohol and diazepam in young and older subjects. J Clin Psychopharmacol 2000;56:453-58.
3. Willumeit HP, Ott H, Neubert W, Hemmerling KG, Schratzer M, Fichte K. Alcohol interaction of lormetazepam, mepindolol sulphate and diazepam measured by performance on the driving simulator. Pharmacopsychiatry 1984;17(2):36-43.
4. Brookhuis KA, Volkerts ER, O'Hanlon JF. Repeated dose effects of lormetazepam and flurazepam upon driving performance. Eur J Clin Pharmacol 1990;39(1):83-87.
5. O'Hanlon JF, Volkerts ER. Hypnotics and actual driving performance. Acta Psychiatr Scand Suppl 1986;332:95-104.
6. van Laar MW, Volkerts E, Verbaten M. Subchronic effects of the GABAagonist lorazepam and the 5-HT2A/2C antagonist ritanserin on driving performance, slow wave sleep and daytime sleepiness in healthy volunteers. Psychopharmacology 2001;154(2):189-97.
7. Staner L, Ertle S, Boeijinga P, Rinaudo G, Arnal MA, Muzet A, Luthringer R. Next-day residual effects of hypnotics in DSM-IV primary insomnia: A driving simulator study with simultaneous electroencephalogram monitoring. Psychopharmacology 2005;181:790-98.
8. van Laar MW, Volkerts ER, van Willigenburg AP. Therapeutic effects and effects on actual driving performance of chronically administered buspirone and diazepam in anxious outpatients. J Clin Psychopharmacol 1992;12(2):86-95.
9. Berthelon C, Bocca ML, Denise P, Pottier A. Do zopiclone, zolpidem and flunitrazepam have residual effects on simulated task of collision anticipation? J Psychopharmacol 2003;17:324-31.
10. Verster JC, Volkerts ER, Verbaten MN. Effects of alprazolam on driving ability, memory functioning and psychomotor performance: A randomized, placebo-controlled study. Neuropsychopharmacology 2002;27:260-69.
11. Verster JC, Veldhuijzen DS, Volkerts ER. Residual effects of sleep medication on driving ability. Sleep Med Rev 2004;8:309-25.
12. Dubois S, Bedard M, Weaver B. The impact of benzodiazepines on safe driving. Traffic Inj Prev 2008;9(5):404-13.
13. Barbone F, McMahon AD, Davey PG, Morris AD, Reid IC, McDevitt DG, Mac- Donald TM. Association of road-traffic accidents with benzodiazepine use. Lancet 1998;352:1331-36.
14. Neutel CI. Risk of traffic accident injury after a prescription for a benzodiazepine. Ann Epidemiol 1995;5:239-44.
15. Drummer OH, Gerostamoulos J, Batziris H, Chu M, Caplehorn JR, Robertson MD, Swann P. The involvement of drugs in drivers of motor vehicles killed in Australian road traffic crashes. Accid Anal Prev 2004;36(2):239-48.
16. Appenzeller BM, Schneider S, Yegles M, Maul A, Wennig R. Drugs and chronic alcohol abuse in drivers. Forensic Sci Int 2005;155(2-3):83-90.
17. Linnoila M, Stapleton JM, Lister R, Moss H, Lane E, Granger A, Eckardt MJ. Effects of single doses of alprazolam and diazepam, alone and in combination with ethanol, on psychomotor and cognitive performance and on autonomic nervous system reactivity in healthy volunteers. Eur J Clin Pharmacol 1990;39(1):21-28.
18. th International Conference on Alcohol, Drugs & Traffic Safety. May 22, 2000.
19. Longo MC, Hunter CE, Lokan RJ, White JM, White MA. The prevalence of alcohol, cannabinoids, benzodiazepines and stimulants amongst injured drivers and their role in driver culpability: Part II: The relationship between drug prevalence and drug concentration, and driver culpability. Accid Anal Prev 2000;32:623-32.
20. Baldock MRJ, McLean AJ. Older drivers: Crash involvements rates and causes. Adelaide, Australia: Centre for Automotive Safety Research, 2005.
21. Oehlert GW. A note on the delta method. Am Stat 1992;46(1):27-29.
22. Engeland A, Skurtveit S, Morland J. Risk of road traffic accidents associated with the prescription of drugs: A registry-based cohort study. Ann Epidemiol 2007;17:597-602.
23. Oster G, Russell MW, Huse DM, Adams SF, Imbimbo J. Accident- and injuryrelated health-care utilization among benzodiazepine users and nonusers. J Clin Psychiatry 1987;48(Suppl):17-21.
24. Hemmelgarn B, Suissa S, Huang A, Boivin JF, Pinard G. Benzodiazepine use and the risk of motor vehicle crash in the elderly. JAMA 1997;278(1):27-31.
25. O'Hanlon JF, Vermeeren A, Uiterwijk MM, van Veggel LM, Swijgman HF. Anxiolytics' effects on the actual driving performance of patients and healthy volunteers in a standardized test. An integration of three studies. Neuropsychobiology 1995;31(2):81-88.